A Shift in Prostate Cancer Treatment is Here
As a physician and a young man with prostate cancer, my research led me to HALO Diagnostics. The time they spent with me convinced me I’d made the right choice for treatment.
The most important risk factor is age: The odds for prostate cancer increase dramatically after men reach 50 years old. The older a man is, the more likely he is to be diagnosed.
Men with first-degree relatives (such as a father, brother, or son) with prostate cancer are more likely to get diagnosed themselves.
African American men are 1.8 times more likely to be diagnosed with prostate cancer and 2.5 times more likely not to survive the disease.
Laser Focal Therapy for Prostate Cancer
Dr. John Feller, Chief Medical Officer at HALO Diagnostics, recently presented 10-year results from our phase II clinical trial of laser focal therapy for prostate cancer.1 The results are impressive.
Prostate cancer survival rate.
Incontinence compared to over 25% risk with whole gland prostatectomy.
Erectile dysfunction compared to ~50% with whole gland prostatectomy.
Infection compared to 4% with whole gland prostatectomy.
What’s Your Risk of Prostate Cancer?
Schedule a Free Consultation
1John Feller, Bernadette Greenwood, Wes Jones, Rob Toth, Steve Gunberg, and Jeffrey Herz. Outpatient Trans-Rectal MR-Guided Laser Focal Therapy Phase II Clinical Trial: Ten-Year Interim Results. PD17. 2020, April 1. J Urol.